428 related articles for article (PubMed ID: 17471309)
1. Recruitment of CD16+ monocytes into synovial tissues is mediated by fractalkine and CX3CR1 in rheumatoid arthritis patients.
Yano R; Yamamura M; Sunahori K; Takasugi K; Yamana J; Kawashima M; Makino H
Acta Med Okayama; 2007 Apr; 61(2):89-98. PubMed ID: 17471309
[TBL] [Abstract][Full Text] [Related]
2. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis.
Ruth JH; Volin MV; Haines GK; Woodruff DC; Katschke KJ; Woods JM; Park CC; Morel JC; Koch AE
Arthritis Rheum; 2001 Jul; 44(7):1568-81. PubMed ID: 11465708
[TBL] [Abstract][Full Text] [Related]
3. Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions.
Ancuta P; Moses A; Gabuzda D
Immunobiology; 2004; 209(1-2):11-20. PubMed ID: 15481136
[TBL] [Abstract][Full Text] [Related]
4. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes.
Ancuta P; Rao R; Moses A; Mehle A; Shaw SK; Luscinskas FW; Gabuzda D
J Exp Med; 2003 Jun; 197(12):1701-7. PubMed ID: 12810688
[TBL] [Abstract][Full Text] [Related]
5. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
6. Fractalkine is a novel chemoattractant for rheumatoid arthritis fibroblast-like synoviocyte signaling through MAP kinases and Akt.
Volin MV; Huynh N; Klosowska K; Chong KK; Woods JM
Arthritis Rheum; 2007 Aug; 56(8):2512-22. PubMed ID: 17665439
[TBL] [Abstract][Full Text] [Related]
7. Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease.
Sans M; Danese S; de la Motte C; de Souza HS; Rivera-Reyes BM; West GA; Phillips M; Katz JA; Fiocchi C
Gastroenterology; 2007 Jan; 132(1):139-53. PubMed ID: 17241867
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis.
Yoshimoto S; Nakatani K; Iwano M; Asai O; Samejima K; Sakan H; Terada M; Harada K; Akai Y; Shiiki H; Nose M; Saito Y
Am J Kidney Dis; 2007 Jul; 50(1):47-58. PubMed ID: 17591524
[TBL] [Abstract][Full Text] [Related]
9. Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis.
Volin MV; Woods JM; Amin MA; Connors MA; Harlow LA; Koch AE
Am J Pathol; 2001 Oct; 159(4):1521-30. PubMed ID: 11583978
[TBL] [Abstract][Full Text] [Related]
10. Recruitment of CD16(+) monocytes to endothelial cells in response to LPS-treatment and concomitant TNF release is regulated by CX3CR1 and interfered by soluble fractalkine.
Rennert K; Heisig K; Groeger M; Wallert M; Funke H; Lorkowski S; Huber O; Mosig AS
Cytokine; 2016 Jul; 83():41-52. PubMed ID: 27031442
[TBL] [Abstract][Full Text] [Related]
11. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow.
Fong AM; Robinson LA; Steeber DA; Tedder TF; Yoshie O; Imai T; Patel DD
J Exp Med; 1998 Oct; 188(8):1413-9. PubMed ID: 9782118
[TBL] [Abstract][Full Text] [Related]
12. Fractalkine expression and CD16+ monocyte accumulation in glomerular lesions: association with their severity and diversity in lupus models.
Nakatani K; Yoshimoto S; Iwano M; Asai O; Samejima K; Sakan H; Terada M; Hasegawa H; Nose M; Saito Y
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F207-16. PubMed ID: 20410215
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase.
Blom AB; Radstake TR; Holthuysen AE; Slöetjes AW; Pesman GJ; Sweep FG; van de Loo FA; Joosten LA; Barrera P; van Lent PL; van den Berg WB
Arthritis Rheum; 2003 Apr; 48(4):1002-14. PubMed ID: 12687542
[TBL] [Abstract][Full Text] [Related]
14. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
[TBL] [Abstract][Full Text] [Related]
15. Fractalkine/CX3CL1 in rheumatoid arthritis.
Nanki T; Imai T; Kawai S
Mod Rheumatol; 2017 May; 27(3):392-397. PubMed ID: 27484962
[TBL] [Abstract][Full Text] [Related]
16. CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis.
Kawanaka N; Yamamura M; Aita T; Morita Y; Okamoto A; Kawashima M; Iwahashi M; Ueno A; Ohmoto Y; Makino H
Arthritis Rheum; 2002 Oct; 46(10):2578-86. PubMed ID: 12384915
[TBL] [Abstract][Full Text] [Related]
17. Viral macrophage inflammatory protein-II and fractalkine (CX3CL1) chimeras identify molecular determinants of affinity, efficacy, and selectivity at CX3CR1.
Davis CN; Zujovic V; Harrison JK
Mol Pharmacol; 2004 Dec; 66(6):1431-9. PubMed ID: 15361546
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of fractalkine ameliorates murine collagen-induced arthritis.
Nanki T; Urasaki Y; Imai T; Nishimura M; Muramoto K; Kubota T; Miyasaka N
J Immunol; 2004 Dec; 173(11):7010-6. PubMed ID: 15557198
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis.
Katschke KJ; Rottman JB; Ruth JH; Qin S; Wu L; LaRosa G; Ponath P; Park CC; Pope RM; Koch AE
Arthritis Rheum; 2001 May; 44(5):1022-32. PubMed ID: 11352233
[TBL] [Abstract][Full Text] [Related]
20. The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.
Pierer M; Brentano F; Rethage J; Wagner U; Hantzschel H; Gay RE; Gay S; Kyburz D
Rheumatology (Oxford); 2007 Jul; 46(7):1063-70. PubMed ID: 17426140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
